Dr Reddys Laboratories has fixed the pricing of the public offering of 12.5 million (excluding the underwriter's over-allotment option) American Depositary Shares ("ADS") at US $16 per ADS. The offering is expected to close on November 22, 2006.
On November 13, 2006, the company filed a shelf registration statement on Form F-3 and preliminary supplement prospectus with the US Securities and Exchange Commission relating to a proposed offering of ADSs of up to 13.5 million shares, excluding the underwriter's over-allotment option.